Biogen Inc.: New Data at ECTRIMS 2022 Highlight Biogen's Commitment to Advancing Individualized Disease Management for People Living with MS

Final safety and efficacy results from the Phase 3 EVOLVE-MS-1 trial demonstrate decreases in disease activity and favorable tolerability for VUMERITY (diroximel fumarate) consistent with previous

Related Keywords

Germany ,Nile ,Tasmania ,Australia ,Ruhr ,Nordrhein Westfalen ,Netherlands ,Bochum ,Cambridge ,Cambridgeshire ,United Kingdom ,Canada ,Switzerland ,German ,Dutch ,Maha Radhakrishnan ,Charles Weissmann ,Walter Gilbert ,Heinz Schaller ,Allison Parks ,Mike Hencke ,Diroximel Fumarate ,Kenneth Murray ,Linkedin ,Twitter ,Unilabs Customer Satisfaction Survey ,Child Development ,Observational Program ,University Bochum ,Nasdaq ,Exchange Commission ,Youtube ,Outcomes On Child Development ,European Union ,Facebook ,Research In Multiple Sclerosis ,European Committee For Treatment ,European Committee ,Multiple Sclerosis ,Chief Medical Officer ,Efficacy Results ,Highlight Patient Reported Outcomes ,Analysis Shows Impact ,Ralf Gold ,Ruhr University Bochum ,Radiologically Isolated Syndrome Reported ,Radiologically Isolated Syndrome ,German Multiple Sclerosis ,Pregnancy Registry ,Data Presentations Featured ,Report Better Outcomes ,Treatment Satisfaction ,Unique Benefits Than Similar Patients Treated ,Pregnancy Outcomes After Long Term Exposure ,Natalizumab During Pregnancy ,German Multicentre ,Open Label Study Over ,Interim Analysis ,Term Effectiveness ,Global Interim Results ,Magnetic Resonance Imaging Endpoints ,Randomized Controlled Study ,Week Dosing ,Week Treatment ,Exposure During Pregnancy ,Natalizumab Patients ,Unilabs Global Cohort Data Descriptive Analysis ,Unilabs Customer Satisfaction Survey Results ,Adjusted Indirect Comparisons ,Relapsing Multiple Sclerosis ,Relapsing Remitting Multiple Sclerosis ,Final Safety ,Beta Exposure During Pregnancy ,Birth Outcome ,Post Authorisation Safety Study ,Double Blinded Assessment ,Dimethyl Fumarate ,First Clinical Demyelinating Event ,West Nile ,Important Safety Informationand ,Prescribing Information ,Medication Guidefor ,Sir Kenneth Murray ,Nobel Prize ,Healthy Lives ,Private Securities Litigation Reform Act ,Biogen ,Data ,Actrims ,022 ,Highlight ,Commitment ,Dvancing ,Individualized ,Disease ,Management ,People ,Diving ,